The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE
Mechanical circulatory support devices for acute right ventricular failure
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
SPECT and PET in ischemic heart failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
Dilated cardiomyopathy: so many cardiomyopathies!
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure